title: Reactive oxygen species participate in the p38-mediated apoptosis induced by potassium deprivation and staurosporine in cerebellar granule neurons.
abstract: Apoptosis induced by low potassium (K5) or staurosporine in cerebellar granule neurons triggers an increase in reactive oxygen species (ROS) levels. ROS inhibition by antioxidants or inhibitors of the NADPH oxidase (NOX) activity reduces the apoptosis induced by both stimuli. It has been reported that JNK mediates the apoptosis induced by K5 but not by staurosporine. No information is available about the role of other signaling pathways such as p38 in staurosporine-induced apoptosis, and whether p38 activation could be related to ROS levels induced by both K5 and staurosporine. Here, we explored this possibility and found that K5 activates p38 and ATF2 and that the inhibition of p38 activity prevents the apoptosis induced by this treatment. We also found that p38 is downstream of ROS generation induced by K5. On the other hand, staurosporine promotes a sustained activation of p38. We found that p38 inhibition markedly decreases ROS generation, NOX activity and apoptosis induced by staurosporine. Furthermore, antioxidants inhibit p38 activation induced by staurosporine. These data indicate that apoptosis induced by both K5 and staurosporine is dependent on p38 activation, which is mediated by ROS. In addition, p38 activation by staurosporine induces a further production of ROS through NOX activation.
authors.affiliation: Division of Neuroscience, Institute of Cell Physiology, National University of Mexico, Mexico City, Mexico.
authors.forename: Yazmín
authors.initials: Y
authors.lastname: Ramiro-Cortés
authors.forename: Alicia
authors.initials: A
authors.lastname: Guemez-Gamboa
authors.forename: Julio
authors.initials: J
authors.lastname: Morán
mesh_terms: D051698:Activating Transcription Factor 2 / Q000378:metabolism; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects*; D020169:Caspases / Q000378:metabolism; D002531:Cerebellum / Q000166:cytology*; D004789:Enzyme Activation / Q000187:drug effects; D057075:Enzyme Assays; D007093:Imidazoles / Q000494:pharmacology; D044949:Kaempferols / Q000494:pharmacology; D019255:NADPH Oxidases / Q000037:antagonists & inhibitors / Q000378:metabolism; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism; D010766:Phosphorylation; D011188:Potassium / Q000502:physiology*; D011725:Pyridines / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D017382:Reactive Oxygen Species / Q000378:metabolism*; D019311:Staurosporine / Q000494:pharmacology*; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism*
chemical_list: D051698:Activating Transcription Factor 2; D000975:Antioxidants; C497107:Atf2 protein, rat; D007093:Imidazoles; D044949:Kaempferols; D011725:Pyridines; D017382:Reactive Oxygen Species; C006552:kaempferol; D019255:NADPH Oxidases; D048051:p38 Mitogen-Activated Protein Kinases; D020169:Caspases; D019311:Staurosporine; C093642:SB 203580; D011188:Potassium